127 related articles for article (PubMed ID: 1974206)
1. Investigation of possible pharmacokinetic and pharmacodynamic interactions between epanolol and digoxin.
Lefebvre RA; Bogaert MG; Duprez D
Eur J Clin Pharmacol; 1990; 38(5):505-7. PubMed ID: 1974206
[TBL] [Abstract][Full Text] [Related]
2. Effects of a single oral administration of Epanolol on exercise tolerance in patients with stable effort angina pectoris.
Vandenbosch H; Piessens J; De Geest H
Acta Cardiol; 1991; 46(1):11-25. PubMed ID: 1674394
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive and hormonal responses to beta-blockade with intrinsic sympathomimetic activity: pindolol versus epanolol.
Simon G; Wittig VJ
J Cardiovasc Pharmacol; 1987 Nov; 10(5):543-7. PubMed ID: 2447403
[TBL] [Abstract][Full Text] [Related]
4. The effect of epanolol on intra-arterial ambulatory blood pressure and baroreceptor heart rate reflex in essential hypertension.
Smith SA; Littler WA
Clin Exp Pharmacol Physiol; 1988 Apr; 15(4):327-31. PubMed ID: 2908433
[TBL] [Abstract][Full Text] [Related]
5. Clinical pharmacology of epanolol. Pharmacodynamic aspects.
Harry JD
Drugs; 1989; 38 Suppl 2():18-27. PubMed ID: 2575976
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamic without pharmacokinetic interaction between cicloprolol, a partial beta 1-adrenoceptor agonist, and digoxin in healthy subjects.
Weber S; Kahan A; Pinquier JL; Julien J; Rosenzweig P; Bianchetti G; Morselli PL; Dessault O; De Lauture D; Strauch G
Br J Clin Pharmacol; 1990 Sep; 30(3):411-6. PubMed ID: 1977438
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of epanolol in elderly patients with stable angina pectoris.
Marlier R; McAinsh J; Cockshott ID
Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):142-4. PubMed ID: 1970734
[TBL] [Abstract][Full Text] [Related]
8. Effects of epanolol and metoprolol on the heart measured by 24-hour holter monitoring.
Withagen AJ; Corbeij HM; Huige MC; Kragten JA; Vermeulen A
Drugs; 1989; 38 Suppl 2():67-9. PubMed ID: 2575985
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of epanolol after acute and chronic oral dosing in elderly patients with stable angina pectoris.
Hosie J; Scott AK; Petrie JC; Cockshott ID
Br J Clin Pharmacol; 1990 Mar; 29(3):333-7. PubMed ID: 1968755
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of epanolol (ICI 141,292) in healthy young volunteers and comparative data in elderly patients with angina and subjects with renal or hepatic impairment.
Cockshott ID
Drugs; 1989; 38 Suppl 2():10-7. PubMed ID: 2575975
[TBL] [Abstract][Full Text] [Related]
11. The effects of beta blockade with (epanolol) and without (atenolol) intrinsic sympathomimetic activity in stable angina pectoris. The Visacor Study Group.
Boberg J; Larsen FF; Pehrsson SK
Clin Cardiol; 1992 Aug; 15(8):591-5. PubMed ID: 1354086
[TBL] [Abstract][Full Text] [Related]
12. Effects of beta-adrenoceptor blockade on heart rate and physiological tremor in diabetics with autonomic neuropathy. A comparative study of epanolol, atenolol and pindolol.
Reid W; Ewing DJ; Harry JD; Smith HJ; Neilson JM; Clarke BF
Br J Clin Pharmacol; 1987 Apr; 23(4):383-9. PubMed ID: 2883987
[TBL] [Abstract][Full Text] [Related]
13. Intrinsic sympathomimetic activity of cardioselective beta-adrenoceptor blockers and effects on renal function.
Mackay IG; Macnicol AM; Smith HJ; Cumming AD; Watson ML
Br J Clin Pharmacol; 1985 Sep; 20(3):197-203. PubMed ID: 2864052
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic and pharmacodynamic studies in man with an antianginal agent 'Visacor'.
Cockshott ID; McAinsh J; Norris S
Biopharm Drug Dispos; 1990 Apr; 11(3):253-63. PubMed ID: 1970266
[TBL] [Abstract][Full Text] [Related]
15. Effects of epanolol, a selective beta1-blocker with intrinsic sympathomimetic activity, in patients with ischemic left ventricular dysfunction.
Van Den Heuvel AF; van der Ent M; van Veldhuisen DJ; Kruijssen DA; Bartels GL; Remme WJ
J Cardiovasc Pharmacol; 1998 Apr; 31(4):506-12. PubMed ID: 9554797
[TBL] [Abstract][Full Text] [Related]
16. Comparative multicentre study of the tolerability and efficacy of epanolol versus nifedipine in patients with stable angina pectoris.
Readman AS
Drugs; 1989; 38 Suppl 2():61-5. PubMed ID: 2575983
[TBL] [Abstract][Full Text] [Related]
17. Epanolol. A new once-daily antianginal agent: dose finding and long term efficacy.
Akhras F; Jackson G
Drugs; 1989; 38 Suppl 2():28-34. PubMed ID: 2575977
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of epanolol versus metoprolol in angina pectoris: report from a Swedish multicentre study of exercise tolerance.
Rydén L
J Intern Med; 1992 Jan; 231(1):7-11. PubMed ID: 1346268
[TBL] [Abstract][Full Text] [Related]
19. The influence of beta-adrenoceptor antagonists with and without partial agonist activity on exercise tolerance and muscle lactate production.
Lees KR; Curzio J; Farish E; Borland WW; Rubin PC
Eur J Clin Pharmacol; 1987; 33(4):415-7. PubMed ID: 2894994
[TBL] [Abstract][Full Text] [Related]
20. Post-exercise hypotension: the effects of epanolol or atenolol on some hormonal and cardiovascular variables in hypertensive men.
Wilcox RG; Bennett T; Macdonald IA; Broughton Pipkin F; Baylis PH
Br J Clin Pharmacol; 1987 Aug; 24(2):151-62. PubMed ID: 2887189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
